CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-24 | Brunn Carsten President and CEO | Grant or award · Employee Stock Option (right to buy) | +163,000 | 163,000 | ||
| 2021-09-20 | Tan Kevin Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2021-09-02 | Brunn Carsten President and CEO | Sale | −4,523 | $4.51 | $20K | 229,372 |
| 2021-09-01 | Brunn Carsten President and CEO | Option exercise | +10,937 | 233,895 | ||
| 2021-09-01 | Brunn Carsten President and CEO | Option exercise · Restricted Stock Units | −10,937 | 54,688 | ||
| 2021-08-18 | BARABE TIMOTHY C Director | Purchase | +9,000 | $4.00 | $36K | 190,013 |
| 2021-06-23 | DeSilva Nishan M Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2021-06-02 | Brunn Carsten President and CEO | Sale | −4,806 | $4.38 | $21K | 222,958 |
| 2021-06-01 | Brunn Carsten President and CEO | Option exercise | +10,938 | 227,764 | ||
| 2021-06-01 | Brunn Carsten President and CEO | Option exercise · Restricted Stock Units | −10,938 | 65,625 | ||
| 2021-05-26 | TRABER PETER G Chief Medical Officer | Purchase | +20,000 | $3.99 | $80K | 135,500 |
| 2021-05-26 | SPRINGER TIMOTHY A Director | Purchase | +926,170 | $4.00 | $3.7M | 19,154,427 |
| 2021-05-25 | SPRINGER TIMOTHY A Director | Purchase | +383,830 | $3.55 | $1.4M | 18,228,257 |
| 2021-05-25 | TRABER PETER G Chief Medical Officer | Purchase | +5,000 | $3.48 | $17K | 115,500 |
| 2021-05-24 | SPRINGER TIMOTHY A Director | Purchase | +590,000 | $3.38 | $2.0M | 17,844,427 |
| 2021-05-24 | TRABER PETER G Chief Medical Officer | Purchase | +12,500 | $3.32 | $41K | 110,500 |
| 2021-05-21 | SPRINGER TIMOTHY A Director | Purchase | +2,773,479 | $3.19 | $8.8M | 17,254,427 |
| 2021-05-07 | Kishimoto Takashi Kei Chief Scientific Officer | Option exercise | +13,629 | $2.77 | $38K | 177,778 |
| 2021-05-07 | Kishimoto Takashi Kei Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −13,629 | 0 | ||
| 2021-03-30 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 24 of 25 · 495 trades